Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C18H22O5S |
Molecular Weight | 350.429 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]3([H])C4=C(CC[C@@]23[H])C=C(OS(O)(=O)=O)C=C4
InChI
InChIKey=JKKFKPJIXZFSSB-CBZIJGRNSA-N
InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1
Molecular Formula | C18H22O5S |
Molecular Weight | 350.429 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 00:29:08 UTC 2023
by
admin
on
Sat Dec 16 00:29:08 UTC 2023
|
Record UNII |
QTL48N278K
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C2181
Created by
admin on Sat Dec 16 00:29:08 UTC 2023 , Edited by admin on Sat Dec 16 00:29:08 UTC 2023
|
||
|
LOINC |
15355-1
Created by
admin on Sat Dec 16 00:29:08 UTC 2023 , Edited by admin on Sat Dec 16 00:29:08 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000124394
Created by
admin on Sat Dec 16 00:29:08 UTC 2023 , Edited by admin on Sat Dec 16 00:29:08 UTC 2023
|
PRIMARY | |||
|
Estrone sulfate (medication)
Created by
admin on Sat Dec 16 00:29:08 UTC 2023 , Edited by admin on Sat Dec 16 00:29:08 UTC 2023
|
PRIMARY | |||
|
C017296
Created by
admin on Sat Dec 16 00:29:08 UTC 2023 , Edited by admin on Sat Dec 16 00:29:08 UTC 2023
|
PRIMARY | |||
|
C1091
Created by
admin on Sat Dec 16 00:29:08 UTC 2023 , Edited by admin on Sat Dec 16 00:29:08 UTC 2023
|
PRIMARY | |||
|
ESTRONE SULFATE
Created by
admin on Sat Dec 16 00:29:08 UTC 2023 , Edited by admin on Sat Dec 16 00:29:08 UTC 2023
|
PRIMARY | |||
|
207-575-9
Created by
admin on Sat Dec 16 00:29:08 UTC 2023 , Edited by admin on Sat Dec 16 00:29:08 UTC 2023
|
PRIMARY | |||
|
QTL48N278K
Created by
admin on Sat Dec 16 00:29:08 UTC 2023 , Edited by admin on Sat Dec 16 00:29:08 UTC 2023
|
PRIMARY | |||
|
4749
Created by
admin on Sat Dec 16 00:29:08 UTC 2023 , Edited by admin on Sat Dec 16 00:29:08 UTC 2023
|
PRIMARY | |||
|
481-97-0
Created by
admin on Sat Dec 16 00:29:08 UTC 2023 , Edited by admin on Sat Dec 16 00:29:08 UTC 2023
|
PRIMARY | |||
|
DB04574
Created by
admin on Sat Dec 16 00:29:08 UTC 2023 , Edited by admin on Sat Dec 16 00:29:08 UTC 2023
|
PRIMARY | |||
|
m5033
Created by
admin on Sat Dec 16 00:29:08 UTC 2023 , Edited by admin on Sat Dec 16 00:29:08 UTC 2023
|
PRIMARY | Merck Index | ||
|
17474
Created by
admin on Sat Dec 16 00:29:08 UTC 2023 , Edited by admin on Sat Dec 16 00:29:08 UTC 2023
|
PRIMARY | |||
|
SUB32459
Created by
admin on Sat Dec 16 00:29:08 UTC 2023 , Edited by admin on Sat Dec 16 00:29:08 UTC 2023
|
PRIMARY | |||
|
3001028
Created by
admin on Sat Dec 16 00:29:08 UTC 2023 , Edited by admin on Sat Dec 16 00:29:08 UTC 2023
|
PRIMARY | |||
|
DTXSID50891501
Created by
admin on Sat Dec 16 00:29:08 UTC 2023 , Edited by admin on Sat Dec 16 00:29:08 UTC 2023
|
PRIMARY | |||
|
4857
Created by
admin on Sat Dec 16 00:29:08 UTC 2023 , Edited by admin on Sat Dec 16 00:29:08 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TRANSPORTER -> SUBSTRATE |
Vmax
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
TRANSPORTER -> INHIBITOR | |||
|
TRANSPORTER -> INHIBITOR |
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT | |||
|
TRANSPORTER -> SUBSTRATE |
Km
|
||
|
TRANSPORTER -> SUBSTRATE |
Km
|
||
|
SALT/SOLVATE -> PARENT | |||
|
TRANSPORTER -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT | |||
|
TRANSPORTER -> SUBSTRATE |
Vmax
|
||
|
TARGET -> INHIBITOR |
|
||
|
TRANSPORTER -> SUBSTRATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
E2 is then extensively metabolized to estrone (E1) (15%), estrone sulfate (E1S) (65%), and other compounds.
|